Professor Tóth's major research interests are: drug delivery, immunoadjuvants, carbohydrates, lipids, peptides, nucleosides, and nucleotides. This research has attracted over $60 million in competitive grants, research contracts and investment funds in the past 10 years.
Professor István Tóth is an Australian Research Council Australian Professorial Fellow; Chair in Biological Chemistry & Professor of Pharmacy at The University of Queensland (UQ), Brisbane, Australia; and Affiliated Professorial Research Fellow and Group Leader at the Institute of Molecular Biosciences, UQ. He graduated with a degree in Chemical Engineering from the Technical University, Budapest, Hungary (1969) and was awarded his PhD (1972) for his Alkaloid Chemistry research. Professor Tóth undertook a postdoctoral fellowship at Carleton University, Ottawa Canada before returning to Hungary to work as a Research Associate (1977-82), then Scientific Group Leader (1982-87) at the Central Research Institute for Chemistry, Hungarian Academy of Science where he earned his Candidate of Science (C.Sc., 1979). He joined the School of Pharmacy at the University of London in 1987 as a Senior Lecturer and Royal Society sponsored Senior Research Fellow. He became a Reader in Medicinal Organic Chemistry in 1994 and was awarded a Doctorate of Science (D.Sc., 1994) for his work in Drug Delivery (Hungarian Academy of Sciences), before relocating to the University of Queensland in 1998 where he has built a productive research group (presently 30 members). Professor Tóth was a visiting professor at the School of Pharmacy, University of London (1994-2004) and at the Department of Bioengineering and Therapeutic Science, University of California, San Francisco (2011-2013).
Professor Tóth has over 300 peer-reviewed publications, 43 patents, and an excellent track record in research commercialisation. He is a one of key founders of Alchemia (ASX listed), Implicit Bioscience Pty Ltd, Neurotide Pty Ltd and TetraQ (the commercial arm of Centre of Integrated Preclinical Drug Development). Professor Tóth is also a Scientific Advisory Board Member of Implicit Bioscience Pty Ltd. Brisbane, Australia, and Proxima Concept Ltd, London, UK.
Professor Tóth is an elected RACI Fellow and Fellow of the Queensland Academy of Arts and Sciences. In 2009 he was awarded the Adrian Albert award for sustained and outstanding research in medicinal biochemistry, and a Business/Higher Education Round Table (BHERT) Award for Outstanding Achievement in International Collaborative Research and Development. Professor Tóth was appointed as a member of the ARC College of Experts (2008-2010). He was the founding (2007) then the elected (2008-2009) President of the Australian Chapter of Controlled Release Society. He is the Editor in Chief of Current Drug Delivery and Drug Delivery Letters, Associate Editor of Medicinal Chemistry; and the Board Member of Mini Reviews in Medicinal Chemistry, Open Drug Delivery, Open Medicinal Chemistry, and Current Patents in Drug Delivery.